New Approaches to Define, Study and Manage the Microbiota and Immune-Mediated Diseases
Friday, September 11, 2015
1:00 - 6:00 p.m.
Medical Education and Telemedicine Building
UC San Diego School of Medicine Campus
Precision medicine utilizes a patient’s biological profile to stratify complex and heterogeneous diseases in order to facilitate evidence-based medicine and improve decision making that improves outcomes. The goal of this symposium is to use clinical scenarios from luminal disease in gastroenterology to illustrate the complexity of disease conditions and how approaches in precision medicine can be applied to improve the stratification of patient phenotype.
Adverse reactions to gluten and approaches to stratify patients.
Elena Verdu, MD, PhD
McMaster University, Canada
Identifying biomarkers in clinical trials.
Gary Firestein, MD
Director, Clinical and Translational Research Institute, UC San Diego
High throughput approaches to associate gene transcription with disease.
Chris Glass, MD, PhD
UC San Diego
Comprehensive approaches to complex diseases. The IBD GEM study.
Ken Croitoru, MD
Mt. Sinai, University of Toronto, Canada
The immunopathology of IBD.
Stephan Targan, MD
Cedars Sinai, Los Angeles, CA
Regulatory T cell therapy in human disease.
Qizhi Tang, PhD
Associate Professor of Surgery, Division of Transplant Surgery; Director, Transplantation Research Laboratory, UCSF.
Application of bioinformatics to understand multiomics.
Trey Ideker, PhD
UC San Diego.
The pipeline of emerging drugs for IBD. Who should receive which drug?
William Sandborn, MD
Division of Gastroenterology, UC San Diego.
Reception with light refreshments to follow